These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4522241)

  • 21. [Characteristics and unknowns of TRIC agents (trachoma--inclusion conjunctivitis)].
    Nabli B
    Rev Int Trach Pathol Ocul Trop Subtrop; 1980; 57(4):71-5. PubMed ID: 7280402
    [No Abstract]   [Full Text] [Related]  

  • 22. [The pathobiology of TRIC agents].
    Jawetz E
    Rev Int Trach; 1973; 50(3):27-38. PubMed ID: 4780351
    [No Abstract]   [Full Text] [Related]  

  • 23. Inclusion bodies in relation to TRIC agent infection.
    Hegab S
    Bull Ophthalmol Soc Egypt; 1971; 64(68):35-42. PubMed ID: 5154731
    [No Abstract]   [Full Text] [Related]  

  • 24. Folliculosis, TRIC (trachoma--inclusion conjunctivitis) and the carrier state.
    Scott JG; Cuthbertson EM; Ryan J
    S Afr J Med Sci; 1972 Jul; 37(1):23-5. PubMed ID: 4656286
    [No Abstract]   [Full Text] [Related]  

  • 25. Conjunctival swabbing for the isolation of TRIC agent (Chlamydia).
    Darougar S; Jones BR
    Br J Ophthalmol; 1971 Sep; 55(9):585-90. PubMed ID: 4938312
    [No Abstract]   [Full Text] [Related]  

  • 26. Interactions of TRIC agents with macrophages: effects on lysosomal enzymes of the cell.
    Taverne J; Blyth WA; Ballard RC
    J Hyg (Lond); 1974 Apr; 72(2):297-309. PubMed ID: 4522724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of chlamydia in irradiated and non-irradiated McCoy cells.
    Johnson L; Harper IA
    J Clin Pathol; 1975 Dec; 28(12):1003-4. PubMed ID: 1107357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the sensitivity of primary isolation of Chlamydia. In irradiated McCoy cells or HeLa 229 cells treated with diethylaminoethyl-dextran (DEAE-D).
    Darougar S; Kundu D; Jones BR
    Br J Ophthalmol; 1974 Oct; 58(10):843-9. PubMed ID: 4615734
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of polycations, polyanions and neuraminidase on the infectivity of trachoma-inclusin conjunctivitis and lymphogranuloma venereum organisms HeLa cells: sialic acid residues as possible receptors for trachoma-inclusion conjunction.
    Kuo CC; Wang SP; Grayston JT
    Infect Immun; 1973 Jul; 8(1):74-9. PubMed ID: 4718924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virulence and host specificity of TRIC agents.
    Moore JE; Griffiths MS; Pearce JH
    J Gen Microbiol; 1969 Dec; 59(3):iv-v. PubMed ID: 4984857
    [No Abstract]   [Full Text] [Related]  

  • 31. Relative sensitivity of cell culture and yolk sac for detection of TRIC infection.
    Gordon FB; Dressler HR; Quan AL
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1044-8. PubMed ID: 6067304
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the iodine and fluorescent antibody methods for staining trachoma inclusions in the conjunctiva.
    Sowa J; Collier LH; Sowa S
    J Hyg (Lond); 1971 Dec; 69(4):693-708. PubMed ID: 4109203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of Chlamydia trachomatis by use of 5-iodo-2-deoxyuridine-treated cells.
    Wentworth BB; Alexander ER
    Appl Microbiol; 1974 May; 27(5):912-6. PubMed ID: 4598224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a further microimmunofluorescence serotype of Chlamydia: TRIC type G.
    Treharne JD; Darougar S; Jones BR
    Br J Vener Dis; 1973 Jun; 49(3):295-300. PubMed ID: 4578214
    [No Abstract]   [Full Text] [Related]  

  • 35. Neutralization of TRIC organisms by antibody: enhancement by antisera prepared against immunoglobulins.
    Blyth WA; Taverne J
    J Hyg (Lond); 1974 Feb; 72(1):129-34. PubMed ID: 4522242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative isolations of TRIC agent in the yolk sacs and the amniotic cavities of chick embryos.
    Harisijades SS; Harisijades BS
    Acta Med Iugosl; 1967; 21(2):223-30. PubMed ID: 4883476
    [No Abstract]   [Full Text] [Related]  

  • 37. Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection. II. Experiments with a 'slow-killing' strain.
    Collier LH; Mogg AE
    J Hyg (Lond); 1969 Sep; 67(3):449-55. PubMed ID: 4980360
    [No Abstract]   [Full Text] [Related]  

  • 38. Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test.
    Alexander ER; Wang SP; Grayston JT
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1469-78. PubMed ID: 6067314
    [No Abstract]   [Full Text] [Related]  

  • 39. Mycoplasmas and "non-specific" genital infection. II. Clinical aspects.
    Dunlop EM; Hare MJ; Jones BR; Taylor-Robinson D
    Br J Vener Dis; 1969 Dec; 45(4):274-81. PubMed ID: 5358971
    [No Abstract]   [Full Text] [Related]  

  • 40. Latency in human infections with TRIC agents.
    Hanna L; Dawson CR; Briones O; Thygeson P; Jawetz E
    J Immunol; 1968 Jul; 101(1):43-50. PubMed ID: 4173937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.